Metraipolis › archive › dc_6e6870eddff1

Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42942810
DOI
10.3390/pharmaceutics18101277
License (as archived)
solo-consultazione
Archived
2026-11-01T05:35:40.430Z
SHA-256 of the archived text
443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe
Stable URL of this page
https://metraipolis.com/documento/dc_6e6870eddff1

How to cite

Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810 — Europe PMC (en), https://europepmc.org/article/MED/42942810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e6870eddff1 (Metraipolis archive dc_6e6870eddff1, sha256 443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe)
BibTeX
@misc{dc6e6870eddff1,
  title = {Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging… — Europe PMC PMID:42942810},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42942810},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e6870eddff1; sha256 443d813973bc7d33c44e926443de2232dae0dba4f543715f3595e6026d1dbcfe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942810. Agents can read the archived copy with the MCP tool read_document.